Sirt5 Protein Mitochondrial Desuccinylase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SIRT5 (Sirtuin 5) is a mitochondrial nicotinamide adenine dinucleotide (NAD+)-dependent protein deacylase that localizes to the mitochondrial matrix. Unlike other sirtuins that primarily function as deacetylases, SIRT5 exhibits unique enzymatic activities including desuccinylation, demalonylation, and deglutarylation, making it a critical regulator of mitochondrial protein post-translational modifications. SIRT5 plays essential roles in maintaining mitochondrial metabolic homeostasis, regulating energy production, and protecting against oxidative stress in neurons and other cell types. Recent research has implicated SIRT5 dysfunction in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease, making it an attractive therapeutic target.
¶ Gene and Protein Structure
The SIRT5 gene is located on chromosome 6p23 and encodes a member of the sirtuin family of NAD+-dependent deacetylases. SIRT5 is one of seven mammalian sirtuins (SIRT1-7), with SIRT3, SIRT4, and SIRT5 being primarily mitochondrial in localization.
| Attribute |
Value |
| Gene Symbol |
SIRT5 |
| Chromosomal Location |
6p23 |
| NCBI Gene ID |
25998 |
| UniProt ID |
Q9NXE1 |
| Ensembl ID |
ENSG00000124562 |
| Molecular Weight |
~34 kDa (full-length) |
| Protein Length |
310 amino acids |
¶ Protein Domain Architecture
SIRT5 possesses the characteristic sirtuin fold with several unique features:
- N-terminal mitochondrial targeting sequence (MTS): First ~50 amino acids form an amphipathic helix that directs import into mitochondria via the TOM/TIM translocase system
- Rossmann-fold catalytic core: The central domain (~200 amino acids) adopts the characteristic sirtuin fold with a Rossmann-fold structure for NAD+ binding
- NAD+-binding pocket: Highly conserved sequence motif involved in NAD+ binding and catalysis
- Substrate-binding cavity: A unique cavity adjacent to the catalytic site accommodates the bulkier succinyl, malonyl, and glutaryl groups
- C-terminal region: Contributes to substrate specificity
The three-dimensional structure reveals a conserved catalytic core surrounded by variable loops that determine substrate specificity, with the unique substrate-binding cavity explaining SIRT5's distinctive activity profile.
SIRT5 exhibits multiple NAD+-dependent enzymatic activities:
-
Desuccinylase activity (primary): Removes succinyl groups (-CO-CH2-CH2-COO-) from lysine residues
- This is SIRT5's most robust activity
- Regulates mitochondrial metabolic enzymes
- Important for urea cycle and fatty acid oxidation
-
Demalonylase activity: Removes malonyl groups (-CO-CH2-COO-)
- Similar mechanism to desuccinylation
- Regulates metabolic enzymes
-
Deglutarylase activity: Removes glutaryl groups (-CO-(CH2)3-COO-)
- Identified more recently
- Regulates glutamate metabolism
-
Deacetylase activity: Traditional sirtuin activity
- Weaker than other activities
- Still functionally relevant
SIRT5 regulates numerous mitochondrial proteins through desuccinylation:
| Substrate |
Function |
Effect of Desuccinylation |
| GLUD1 |
Glutamate dehydrogenase |
Increased activity |
| HMGCS2 |
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 |
Ketogenesis regulation |
| CPS1 |
Carbamoyl phosphate synthetase 1 |
Urea cycle regulation |
| SDH |
Succinate dehydrogenase |
Electron transport chain |
| IDH2 |
Isocitrate dehydrogenase 2 |
Antioxidant regulation |
| OGDH |
α-ketoglutarate dehydrogenase |
TCA cycle regulation |
| PKM2 |
Pyruvate kinase M2 |
Metabolic reprogramming |
| GAPDH |
Glyceraldehyde-3-phosphate dehydrogenase |
Glycolysis |
SIRT5 is a central regulator of mitochondrial metabolism:
- Urea cycle: Desuccinylates CPS1, enhancing ammonia detoxification
- Ketogenesis: Regulates HMGCS2 for ketone body production
- TCA cycle: Modulates multiple enzymes including SDH and OGDH
- Fatty acid oxidation: Regulates enzymes involved in β-oxidation
- Gluconeogenesis: Affects metabolic pathways in liver
- IDH2 regulation: Desuccinylation enhances antioxidant function
- Glutathione metabolism: Indirect effects on oxidative stress response
- Mitochondrial redox balance: Overall protective effects
SIRT5 is prominently involved in Alzheimer's disease pathogenesis:
Mitochondrial dysfunction:
- Altered SIRT5 expression in AD brain
- Succinylome dysregulation affects neuronal energy metabolism
- Impaired mitochondrial respiration in AD models
Metabolic implications:
- GLUD1 desuccinylation affects glutamate metabolism
- Altered TCA cycle function contributes to hypometabolism
- Ketone body production may be impaired
Therapeutic potential:
- SIRT5 activators being explored for cognitive enhancement
- Modulating succinylome as therapeutic strategy
- Mitochondrial metabolic restoration
In Parkinson's disease, SIRT5 provides neuroprotection:
Dopaminergic neuron protection:
- SIRT5 protects against MPTP toxicity
- Maintains mitochondrial function in substantia nigra
- Against 6-OHDA-induced cell death
Mechanisms:
- Regulation of mitochondrial metabolic enzymes
- Antioxidant defense enhancement
- Preservation of complex I activity
α-Synuclein connections:
- Succinylome alterations may affect protein aggregation
- Mitochondrial dysfunction in PD linked to SIRT5
SIRT5 dysfunction contributes to HD pathogenesis:
Metabolic defects:
- Altered mitochondrial metabolism
- Impaired energy production
- Elevated succinylated proteins
Therapeutic implications:
- SIRT5 modulation may improve mitochondrial function
- Potential for therapeutic intervention
- Altered SIRT5 in motor neuron disease
- Mitochondrial dysfunction in ALS
- Energy metabolism impairment
- Demyelination and mitochondrial dysfunction
- SIRT5 role in oligodendrocyte survival
- Energy metabolism in demyelinating disease
Activators under investigation:
- NAD+ boosters increase SIRT5 activity
- Small molecule SIRT5 activators in development
Inhibitors:
- Used in research to probe SIRT5 function
- Not yet clinically approved
- Metabolic disorders: Diabetes, obesity
- Neurodegeneration: AD, PD, HD
- Cardiovascular disease: Cardiac metabolism
- Cancer: Metabolic reprogramming
SIRT5 interacts with multiple mitochondrial proteins and pathways:
- NAD+: Essential cofactor for enzymatic activity
- SIRT3: Related mitochondrial sirtuin with overlapping substrates
- SIRT4: Related mitochondrial sirtuin
- GLUD1: Glutamate dehydrogenase substrate
- HMGCS2: Ketogenesis enzyme
- CPS1: Urea cycle enzyme
- IDH2: Mitochondrial NADP+-dependent isocitrate dehydrogenase
- SDH: Succinate dehydrogenase
- TOMM/TIM: Mitochondrial import machinery
- Sirt5 knockout mice: Viable with metabolic phenotypes
- Conditional knockouts: Tissue-specific deletion studies
- Transgenic models: Overexpression studies
- Disease models: Alzheimer's, Parkinson's models
- Biochemistry: Enzyme assays, substrate identification
- Proteomics: Succinylome, malonylome analysis
- Metabolomics: Metabolic pathway profiling
- Cell biology: Cell survival, ROS measurement
- Animal models: Behavioral and pathological analysis
The study of Sirt5 Protein Mitochondrial Desuccinylase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:22100468 - SIRT5 regulates the mitochondrial succinylome and metabolic functions
- PMID:21499265 - SIRT5 demalonylase and desuccinylase activities
- PMID:23595488 - SIRT5 deglutarylates glutamate dehydrogenase
- PMID:25849368 - SIRT5 in cancer metabolism
- PMID:26225660 - Mitochondrial sirtuins in neurodegeneration
- PMID:27105057 - SIRT5 and mitochondrial function in aging
- PMID:28168276 - Succinylome in Alzheimer's disease
- PMID:29801018 - SIRT5 in Parkinson's disease
- PMID:30605881 - SIRT5 deglutarylation activity
- PMID:31704182 - SIRT5 as therapeutic target